Hepatitis B: What Did Albania and Armenia Achieve?
Source announcement: . Published by iMedic on October 13, 2026.
Quick Facts
Key takeaways
- The finding concerns the surveyed childhood population.
- Vaccination and prevention of transmission at birth remain important.
What supported the validation?
The WHO regional announcement describes assessment by immunization experts. An estimated prevalence of zero in the surveys should be read within their age group and study scope.
Why does preventing childhood infection matter?
According to WHO background guidance, chronic hepatitis B can lead to liver scarring and liver cancer. Preventing infection protects health over decades.
What prevention remains necessary?
WHO recommends a birth dose within 24 hours, followed by the remaining infant doses. Testing during pregnancy supports measures to prevent transmission to the baby. Existing infections still need assessment and, when indicated, treatment.
Frequently Asked Questions
No. It confirms specific control targets, not the absence of all infections.
No. The reported survey finding concerned children aged 6–8.
Yes. Vaccination is an effective preventive measure.
Yes. Laboratory testing may be needed.
No. Established infection requires its own clinical assessment.
References
- WHO Europe: Albania and Armenia hepatitis B milestone. Checked October 13, 2026.
- WHO: hepatitis B prevention and care. Checked October 13, 2026.
How was this news summary prepared?
iMedic Editorial Team checked this summary against the primary sources linked above. It reports a dated announcement and its limitations; it is not an individual treatment recommendation. Editorial standards.